Measure Number Theme Measure Description & Provenance Name of KPI Numerator Denominator Period Type Frequency Data Source Numerator Data Source Denominator Data presentation Target Interpretation Guidance Construction Data Quality Concerns Notes_1 HPB01 Domain 3: Helping Proportion of patients with adenocarcinoma of people to recover from the pancreas who have a curative resection episodes of ill health or following injury Number of patients who have curative Number of patients with adenocarcinoma of the Annual resection pancreas Annual Provider Provider HPB02 Domain 3: Helping Mortality rate within 30 days of cureative people to recover from resection for adenocarcinoma of the pancreas episodes of ill health or following injury Number of patients who die within 30 Number of patients with adenocarcinoma of the Annual days of curative resection pancreas who have a curative resection Annual Provider Provider HPB03 Domain 3: Helping Mortality rate within 90 days of curative people to recover from resection for adenocarcinoma of the pancreas episodes of ill health or following injury Number of patients who die within 90 Number of patients with adenocarcinoma of the Annual days of curative resection pancreas who have a curative resection Annual Provider Provider HPB04 Domain 3: Helping 5 year survival of patients with adenocarcinoma people to recover from of the pancreas - all patients discussed at MDT episodes of ill health or following injury Annual Annual TBC TBC further guidance needed - not to be collected currently HPB05 Domain 3: Helping 5 year survival of patients with adenocarcinoma people to recover from of the pancreas - all patients discussed at MDT episodes of ill health or who undergo resection with curative intent following injury Annual Annual TBC TBC further guidance needed - not to be collected currently HPB07 Domain 3: Helping LOS after pancreatico-duodenectomy (J56X) for people to recover from pancreatic adenocarcinoma episodes of ill health or following injury Number of days (LOS) Number of pancreatico-duodenectomy (J56X) for pancreatic adenocarcinoma in reporting period Annual Annual HES HES HPB08 Domain 3: Helping Emergency readmission within 30 days of people to recover from pancreatico-duodenectomy for pancreatic episodes of ill health or adenocarcinoma following injury From denominator, number of emergency readmissions within 30 days Number of pancreatico-duodenectomy (J56X) for pancreatic adenocarcinoma in reporting period Annual Annual Provider Provider HPB09 Domain 3: Helping Re-operation rates within 30 days of pancreaticopeople to recover from duodenectomy for pancreatic adenocarcinoma episodes of ill health or following injury From denominator, number of re operations within 30 days Number of pancreatico-duodenectomy (J56X) for pancreatic adenocarcinoma in reporting period Annual Annual Provider Provider HPB10 Domain 3: Helping Proportion of patients with pancreatic people to recover from adenocarcinoma who do not undergo curative episodes of ill health or resection who receive palliative chemotherapy following injury From denominator, number receiving Number of patients with pancreatic palliative chemotherapy adenocarcinoma not undergoing curative resection Annual Annual Provider Provider HPB13 Domain 3: Helping Mean duration from date of referral by GP (or people to recover from emergency admission to hospital) to curative episodes of ill health or resection following injury Total length of time from referral or emergency admissions Annual Annual Provider Provider HPB14 Domain 3: Helping people to recover from episodes of ill health or following injury From denominator, number receiving Number of patients with pancreatic head or curative resection without initial stent uncinate adenocarcinoma with serum bilirubin placement <200mg/dl at presentation Annual Annual Provider Provider HPB16 Domain 3: Helping Proportion of patients with colorectal liver people to recover from metastases whose imaging is discussed at HPB episodes of ill health or MDT following injury From denominator, number whose imaging is discussed at HPB MDT Number of patients with colorectal liver metastases Annual Annual Provider Provider HPB17 Domain 3: Helping Proportion of patients with colorectal liver people to recover from metastases undergoing resection episodes of ill health or following injury From denominator, number undergoing resection Number of patients with colerectal liver metastases Annual Annual Provider Provider HPB18 Domain 3: Helping Length of stay after right hemi-hepatectomy for people to recover from colorectal cancer liver metastases episodes of ill health or following injury Length of stay (in days) Number of patients having right hemihepatectomy for colorectal cancer liver metastases Annual Annual Provider Provider HPB19 Domain 4: Ensuring that people have a positive experience of care Domain 5: Treating and caring for people in a safe environment and protecting them from avoidable harm Emergency readmission rate at 30 days after right hemi-hepatectomy for colorectal cancer liver metastases From denominator, number of emergency readmissions within 30 days Number of patients having right hemihepatectomy for colorectal cancer liver metastases Annual Annual Provider Provider 30 day mortality after right hemi-hepatectomy for colorectal cancer liver metastases Number of patients who die within 30 Number of patients having right hemidays of right hemi-hepatectomy hepatectomy for colorectal cancer liver metastases Annual Annual Provider Provider HPB20 Proportion of patients with pancreatic head or uncinate adenocarcinoma with serum bilirubin <200mg/dl at presentation receiving curative resection without initial stent placement Number of patients having curative resection HPB21 HPB22 HPB23 HPB24 Domain 4: Ensuring that people have a positive experience of care Domain 4: Ensuring that people have a positive experience of care Domain 4: Ensuring that people have a positive experience of care Domain 5: Treating and caring for people in a safe environment and protecting them from avoidable harm 90 day mortality after right hemi-hepatectomy for colorectal cancer liver metastases Number of patients who die within 90 Number of patients having right hemidays of right hemi-hepatectomy hepatectomy for colorectal cancer liver metastases Annual Annual Annual Annual Annual Annual 30 day survival for patients with colorectal liver metastases receiving ablation without resection, with curative intent Annual Annual Domain 4: Ensuring that people have a positive experience of care Domain 4: Ensuring that people have a positive experience of care Domain 5: Treating and caring for people in a safe environment and protecting them from avoidable harm 5 year survival for patients with colorectal liver metastases receiving ablation without resection, with curative intent Annual Annual Domain 4: Ensuring that people have a positive experience of care Domain 5: Treating and caring for people in a safe environment and protecting them from avoidable harm Provider 5 year survical after right hemi-hepatectomy for colorectal cancer liver metastases Proportion of patients with colorectal liver metastases receiving ablation without resection, with curative intent From denominator, number receiving Number of patients with colorectal liver ablation without resection with metastases curative intent further guidance needed - not to be collected currently TBC TBC Provider Provider further guidance needed - not to be collected currently TBC HPB25 HPB27 HPB28 HPB29 HPB30 Percentage of patients with hepatocellular carcinoma receiving treatment with curative intent from denominator, number receiving treatment with curative intent Number of patients with hepatocellular carcinoma Annual Annual Percentage of patients with hepatocellular carcinoma receiving liver transplant from denominator, number receiving liver transplant Number of patients with hepatocellular carcinoma Annual Annual Median survival for patients with HCC treated with curative intent Annual Annual Median survival for patients with HCC treated with palliative intent Annual Annual Annual Annual Annual Annual TBC TBC Provider Provider Provider Provider further guidance needed - not to be collected currently TBC HPB32 Domain 4: Ensuring Median survival after liver transplant for benign that people have a disease positive experience of care Domain 5: Treating 5 year survival after liver transplant for HCC and caring for people in a safe environment and protecting them from avoidable harm TBC further guidance needed - not to be collected currently TBC further guidance needed - not to be collected currently TBC HPB31 Provider TBC further guidance needed - not to be collected currently TBC TBC further guidance needed - not to be collected currently TBC TBC ROCR/OR/2230/001MAND
© Copyright 2024